# SVBP

## Overview
The SVBP gene encodes the small vasohibin binding protein, a critical component in the regulation of microtubule dynamics through its role in tubulin detyrosination. This protein functions as a chaperone-like molecule, forming complexes with vasohibins, specifically VASH1 and VASH2, which are enzymes responsible for the detyrosination of α-tubulin. The detyrosination process is a post-translational modification that influences microtubule stability and interactions with motor proteins, impacting cellular processes such as neuron development, mitosis, and muscle function (Aillaud2017VasohibinsSVBP; Wang2019Structural). Structurally, SVBP is characterized by a transglutaminase-like fold and forms heterodimeric or heterotetrameric complexes with vasohibins, enhancing their solubility and enzymatic activity (Wang2019Structural; Ikeda2020The). Mutations in the SVBP gene have been linked to neurological disorders, underscoring its importance in the central nervous system and its potential clinical significance (Pagnamenta2019Defective; Iqbal2019Loss).

## Structure
The small vasohibin binding protein (SVBP) is a crucial component in the regulation of vasohibin activity, particularly in the context of tubulin detyrosination. The primary structure of SVBP includes a sequence that allows it to form a stable complex with vasohibins, enhancing their solubility, stability, and enzymatic activity (Wang2019Structural). 

In terms of secondary structure, SVBP forms a three-helix bundle when interacting with vasohibins, as seen in the V2c-SVBP complex (Wang2019Structural). This structural arrangement is essential for its role as an activator of vasohibins, facilitating the detyrosination of tubulin (Wang2019Structural).

The tertiary structure of SVBP, when bound to vasohibins, reveals a transglutaminase-like fold, which is characteristic of the transglutaminase-like cysteine protease superfamily (Wang2019Structural). This fold is crucial for the enzymatic function of the vasohibin-SVBP complex.

SVBP's quaternary structure involves forming a heterodimer or heterotetramer with vasohibins, such as VASH1, which is stabilized by interactions including hydrogen bonds and hydrophobic contacts (Ikeda2020The). These interactions are vital for the complex's enzymatic activity and regulation. 

Post-translational modifications, such as phosphorylation at conserved sites like Y40, may regulate SVBP's interaction with vasohibins, impacting its function in neuronal development (Wang2019Structural).

## Function
SVBP (small vasohibin binding protein) functions as a chaperone-like protein that plays a crucial role in the detyrosination of α-tubulin, a post-translational modification important for various cellular processes. It forms a complex with vasohibins, specifically VASH1 and VASH2, which are tubulin carboxypeptidases responsible for removing the C-terminal tyrosine from α-tubulin. This detyrosination process is essential for regulating microtubule dynamics, affecting their stability and interactions with motor proteins, which are critical for neuron development, mitosis, and muscle function (Aillaud2017VasohibinsSVBP; Wang2019Structural; Zhou2019Structural).

SVBP enhances the solubility, stability, and enzymatic activity of vasohibins, facilitating their function in the detyrosination-tyrosination cycle of tubulin. This cycle is vital for cellular activities such as chromosome motion during mitosis, axon specification in neurons, and cardiomyocyte contraction (Wang2019Structural; Li2020CryoEM). In neurons, SVBP is essential for maintaining detyrosinated tubulin levels, which are crucial for neuron differentiation and proper brain development (Aillaud2017VasohibinsSVBP). Loss of SVBP function can lead to neurological disorders, highlighting its importance in the central nervous system (Iqbal2019Loss).

## Clinical Significance
Mutations in the SVBP gene are associated with several neurological and developmental disorders. Loss-of-function mutations in SVBP have been linked to autosomal recessive intellectual disability, microcephaly, ataxia, and hypotonia. These mutations often result in a truncated, nonfunctional protein, leading to impaired interactions with vasohibin proteins, which are crucial for tubulin detyrosination (Pagnamenta2019Defective; Iqbal2019Loss). The c.82C>T; p.Q28* variant is a specific mutation identified in multiple families, causing structural brain abnormalities and cognitive deficiencies due to defective tubulin detyrosination (Pagnamenta2019Defective).

SVBP mutations disrupt the detyrosination-tyrosination cycle of α-tubulin, affecting microtubule dynamics and leading to reduced brain volume and abnormal neuronal differentiation (Pagnamenta2019Defective). These disruptions are linked to developmental delays, spasticity, and other neurological symptoms (Pagnamenta2019Defective). The clinical significance of SVBP mutations is underscored by their impact on brain structure and function, highlighting the gene's role in neurodevelopmental pathologies (Li2020CryoEM). These findings suggest that alterations in SVBP expression or interaction could have significant clinical implications, particularly in diseases linked to microtubule dysfunction (Li2020CryoEM).

## Interactions
SVBP (small vasohibin binding protein) interacts with vasohibin proteins, specifically VASH1 and VASH2, forming heterodimeric complexes that are crucial for the detyrosination of α-tubulin. SVBP acts as a stabilizing factor, enhancing the solubility and enzymatic activity of VASH1 and VASH2. This interaction is essential for the detyrosination process, which is important for various cellular functions, including neuron differentiation and mitosis (Aillaud2017VasohibinsSVBP; Liao2019Molecular; Zhou2019Structural).

The SVBP-VASH1 complex has been shown to catalyze the detyrosination of a peptide derived from the C-terminal sequence of TUBA1A, with SVBP enhancing the solubility and stability of VASH1. Specific residues in SVBP, such as Gln35, Arg36, Leu42, and Asn43, are crucial for binding to VASH1, indicating an allosteric regulatory role in the detyrosination process (Liao2019Molecular).

SVBP also interacts with VASH2, stabilizing its α1 and α2 helices, which are essential for VASH2's solubility and activity. The VASH2/SVBP complex features a positively charged groove around the catalytic pocket, crucial for recognizing and detyrosinating the tubulin tail (Zhou2019Structural). These interactions highlight SVBP's role in facilitating the proper function of vasohibins in cellular processes.


## References


[1. (Iqbal2019Loss) Zafar Iqbal, Hasan Tawamie, Wei Ba, André Reis, Bassam Al Halak, Heinrich Sticht, Steffen Uebe, Nael Nadif Kasri, Sheikh Riazuddin, Hans van Bokhoven, and Rami Abou Jamra. Loss of function of svbp leads to autosomal recessive intellectual disability, microcephaly, ataxia, and hypotonia. Genetics in Medicine, 21(8):1790–1796, August 2019. URL: http://dx.doi.org/10.1038/s41436-018-0415-8, doi:10.1038/s41436-018-0415-8. This article has 25 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41436-018-0415-8)

[2. (Li2020CryoEM) Faxiang Li, Yang Li, Xuecheng Ye, Haishan Gao, Zhubing Shi, Xuelian Luo, Luke M Rice, and Hongtao Yu. Cryo-em structure of vash1-svbp bound to microtubules. eLife, August 2020. URL: http://dx.doi.org/10.7554/elife.58157, doi:10.7554/elife.58157. This article has 22 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.7554/elife.58157)

[3. (Wang2019Structural) Na Wang, Christophe Bosc, Sung Ryul Choi, Benoit Boulan, Leticia Peris, Natacha Olieric, Hongyu Bao, Fatma Krichen, Liu Chen, Annie Andrieux, Vincent Olieric, Marie-Jo Moutin, Michel O. Steinmetz, and Hongda Huang. Structural basis of tubulin detyrosination by the vasohibin–svbp enzyme complex. Nature Structural &amp; Molecular Biology, 26(7):571–582, June 2019. URL: http://dx.doi.org/10.1038/s41594-019-0241-y, doi:10.1038/s41594-019-0241-y. This article has 45 citations.](https://doi.org/10.1038/s41594-019-0241-y)

[4. (Zhou2019Structural) Chen Zhou, Ling Yan, Wen-hui Zhang, and Zhu Liu. Structural basis of tubulin detyrosination by vash2/svbp heterodimer. Nature Communications, July 2019. URL: http://dx.doi.org/10.1038/s41467-019-11277-8, doi:10.1038/s41467-019-11277-8. This article has 26 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-019-11277-8)

[5. (Aillaud2017VasohibinsSVBP) Chrystelle Aillaud, Christophe Bosc, Leticia Peris, Anouk Bosson, Pierre Heemeryck, Juliette Van Dijk, Julien Le Friec, Benoit Boulan, Frédérique Vossier, Laura E. Sanman, Salahuddin Syed, Neri Amara, Yohann Couté, Laurence Lafanechère, Eric Denarier, Christian Delphin, Laurent Pelletier, Sandrine Humbert, Matthew Bogyo, Annie Andrieux, Krzysztof Rogowski, and Marie-Jo Moutin. Vasohibins/svbp are tubulin carboxypeptidases (tcps) that regulate neuron differentiation. Science, 358(6369):1448–1453, December 2017. URL: http://dx.doi.org/10.1126/science.aao4165, doi:10.1126/science.aao4165. This article has 209 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1126/science.aao4165)

[6. (Liao2019Molecular) Shanhui Liao, Girish Rajendraprasad, Na Wang, Susana Eibes, Jun Gao, Huijuan Yu, Gao Wu, Xiaoming Tu, Hongda Huang, Marin Barisic, and Chao Xu. Molecular basis of vasohibins-mediated detyrosination and its impact on spindle function and mitosis. Cell Research, 29(7):533–547, June 2019. URL: http://dx.doi.org/10.1038/s41422-019-0187-y, doi:10.1038/s41422-019-0187-y. This article has 59 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/s41422-019-0187-y)

[7. (Ikeda2020The) Akihito Ikeda, Seia Urata, Tadashi Ando, Yasuhiro Suzuki, Yasufumi Sato, and Tatsuya Nishino. The crystal structure of the tetrameric human vasohibin-1–svbp complex reveals a variable arm region within the structural core. Acta Crystallographica Section D Structural Biology, 76(10):993–1000, September 2020. URL: http://dx.doi.org/10.1107/s2059798320011298, doi:10.1107/s2059798320011298. This article has 2 citations.](https://doi.org/10.1107/s2059798320011298)

[8. (Pagnamenta2019Defective) Alistair T Pagnamenta, Pierre Heemeryck, Hilary C Martin, Christophe Bosc, Leticia Peris, Ivy Uszynski, Sylvie Gory-Fauré, Simon Couly, Charu Deshpande, Ata Siddiqui, Alaa A Elmonairy, Sandeep Jayawant, Sarada Murthy, Ian Walker, Lucy Loong, Peter Bauer, Frédérique Vossier, Eric Denarier, Tangui Maurice, Emmanuel L Barbier, Jean-Christophe Deloulme, Jenny C Taylor, Edward M Blair, Annie Andrieux, and Marie-Jo Moutin. Defective tubulin detyrosination causes structural brain abnormalities with cognitive deficiency in humans and mice. Human Molecular Genetics, 28(20):3391–3405, July 2019. URL: http://dx.doi.org/10.1093/hmg/ddz186, doi:10.1093/hmg/ddz186. This article has 47 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddz186)